| Ytd | -44.66% | |
| 1y | -49.41% |
| Open | 218.71 | Prev Close | 216.98 | Low | 216.50 | High | 223.44 | Mkt Cap | 29.45B |
| Vol | 514.98K | Avg Vol | 1.60M | EPS | 5.55 | P/E | 39.65 | Forward P/E | 17.40 |
| Beta | 0.30 | Short Ratio | 3.62 | Inst. Own | 102.17% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 278.68 | 200-d Avg | 341.55 | 1yr Est | 375.76 |
Investors need to pay close attention to ALNY stock based on the movements in the options market lat
LOS ANGELES, Aug. 4, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national sharehold
Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourage In
LOS ANGELES, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP, a leading national
BENSALEM, Pa., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith continues its invest
LOS ANGELES, Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its invest
[url="]Schall, Brown and Schwartz[/url] LLP (âSBSâ), a national shareholder rights litigation fi
LOS ANGELES--(BUSINESS WIRE)---- $ALNY--ALNY Investors Have Opportunity to Join Alnylam Pharmaceutic
NEW YORK, July 31, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating pot
Alnylam stock plunges after Q2 earnings and revenue miss estimates, while a cut to 2026 product sale
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder righ
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Alnylam
Alnylam Pharmaceuticals, Inc. (ALNY) Q2 2026 Earnings Call Transcript
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) stock plunged on Thursday after the company lowered its f
Alnylam cut its 2026 sales outlook despite a Q2 earnings beat as slower ATTR-CM market growth weighe
Microsoft's 43% cloud growth revived the AI trade and lifted chipmakers, but Meta's guidance
Gainers Nuwellis (NASDAQ:NUWE) stock moved upwards by 123.7% to $4.23 during Thursday's regular
US stocks gain, Dow up 300 points as tech shares surge 5.3%, Bristol-Myers Squibb beats expectation
The headline numbers for Alnylam (ALNY) give insight into how the company performed in the quarter e
Alnylam Pharmaceuticals (ALNY) came out with quarterly earnings of $1.84 per share, missing the Zack
Alnylam Pharmaceuticals NASDAQ: ALNY reported second-quarter 2026 global net product revenue of appr
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi th
Beyond analysts' top-and-bottom-line estimates for Alnylam (ALNY), evaluate projections for some of
− Initiates Global Phase 2 APPlauDS Study of Mivelsiran in Down Syndrome–Associated Alzheimer’s Dise
B of A Securities analyst Tazeen Ahmad maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy
Truist Securities analyst Danielle Brill maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a B
HC Wainwright & Co. analyst Patrick R. Trucchio maintains Alnylam Pharmaceuticals (NASDAQ:ALN
Ionis and AstraZeneca's Phase 3 ATTR-CM trial misses its primary goal, analyst says the outcome
U.S. stocks higher, Nasdaq up 150+ points. Aehr Test Systems shares rose 13.6%. Other big gainers in
Gainers Virax Biolabs Group (NASDAQ:VRAX) stock increased by 134.0% to $7.44 during Thursday's
Stocks moving: RPGL +54.5%, EDBL +42.5%, SDOT +27.4%, BJDX +24.6%, AP +19.9%, SUNE +18%, ALNY +15.3%
Top Wall Street analysts upgraded and downgraded several top companies, including Applied Materials,
U.S. stock futures down, Nasdaq 100 falls over 100 points. Mach Natural Resources LP (MNR) shares di
Gold and silver surged to fresh record highs Monday as investors reassessed the Federal Reserve'
The Nasdaq-100 Index has announced its annual reconstitution, with six new companies being added and
As a result of the reconstitution, the following six companies will be removed from the Index: Bioge
Royalty Pharma plc (NASDAQ:RPRX) today announced that it has acquired a royalty interest in Alnylam&
Intellia Therapeutics (NASDAQ: NTLA) paused their Phase 3 MAGNITUDE and MAGNITUDE-2 trials after a s
The top 10 large-cap stocks in the last week were RIVN, CUK, FDX, IOT, SUZ, CVNA, FTAI, RDDT, MDB, a
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earning